Tara Gregory, MD, has completed qualifications in Hispanic Studies and Molecular and Cellular Biology, as well as medical training at the University of Arizona School of Medicine, Tuscon, AZ. She then trained as an internal medicine resident at Banner University Medical Center, Tuscon, AZ, and completed a medical oncology fellowship at the University of Colorado.
Dr Gregory is a long-standing member of the Colorado Blood Cancer Institute. Having joined in 2009, she is currently a member physician, co-director of the Plasma Cell Dyscrasia Program, director of the Unrelated Donor Program and part of the Plasma Cell Disease Group. She is a member of numerous societies, including the American Society of Hematology, the American Society of Clinical Oncology and the American Society for Transplantation and Cellular Therapy, where she is part of the National Leadership Program.
Speaking on clinical trials in CAR T-cell therapy
Dr Gregory carries out research into multiple myeloma treatment options, notably CAR T-cell therapy. She is also involved in clinical trials with focuses including novel CAR T-cells and blood and marrow transplant outcomes. She is passionate about improving patient education and ensuring treatment decisions are made in partnership with patients.